Review: taking Zofran and Zantac together


Summary

Drug interactions are reported among people who take Zofran and Zantac together. This review analyzes the effectiveness and drug interactions between Zofran and Zantac. It is created by eHealthMe based on reports of 5,195 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Zofran

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. (latest outcomes from Zofran 36,472 users)

Zantac

Zantac has active ingredients of ranitidine hydrochloride. It is often used in indigestion. (latest outcomes from Zantac 46,871 users)

On Sep, 16, 2016

5,195 people who take Zofran, Zantac are studied.


Number of reports submitted per year:

Zofran and Zantac drug interactions.

Drug effectiveness over time:

Zofran:
  • < 1 month: 25.0% - (1 of 4 people)
  • 1 - 6 months: 28.0% - (2 of 7 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 66.0% - (2 of 3 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Zantac:
  • < 1 month: 0.0% - (0 of 6 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 66.0% - (2 of 3 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Zofran:
  • female: 35.0% - (5 of 14 people)
  • male: 50.0% - (1 of 2 people)
Zantac:
  • female: 23.0% - (3 of 13 people)
  • male: 50.0% - (1 of 2 people)

Drug effectiveness by age:

Zofran:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 50.0% - (2 of 4 people)
  • 30-39: 0.0% - (0 of 3 people)
  • 40-49: 100.0% - (2 of 2 people)
  • 50-59: 33.0% - (1 of 3 people)
  • 60+: 33.0% - (1 of 3 people)
Zantac:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 4 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 33.0% - (1 of 3 people)
  • 60+: 33.0% - (1 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • dyspnoea
  • nausea
  • pyrexia
  • diarrhoea
  • vomiting
  • hypotension
  • tachycardia
  • erythema
  • abdominal pain
  • pneumonia
1 - 6 months:
  • febrile neutropenia
  • dehydration
  • nausea
  • pneumonia
  • diarrhoea
  • abdominal pain
  • dyspnoea
  • pulmonary embolism
  • vomiting
  • pain
6 - 12 months:
  • dyspnoea
  • fatigue
  • asthenia
  • cough
  • dizziness
  • feeling abnormal
  • lung disorder
  • peripheral motor neuropathy
  • red blood cell count decreased
  • respiratory tract irritation
1 - 2 years:
  • decreased appetite
  • fatigue
  • atrial septal defect
  • bundle branch block right
  • cardiac murmur
  • cardiomegaly
  • crepitations
  • cyanosis
  • diarrhoea
  • drug exposure during pregnancy
2 - 5 years:
  • depression
  • headache
  • hypokalaemia
  • pain of skin
  • anxiety, apprehension, feeling uptight, jitters, stress, stress and anxiety, tension
  • burning eyes
  • capillary leak syndrome
  • chronic pain
  • chronic pancreatitis
  • chronic sinusitis
5 - 10 years:
  • burning eyes
  • abscess - skin
  • back pain
  • body temperature fluctuation
  • breath odor
  • breathing difficulty
  • cardio-respiratory arrest
  • chest tightness or pressure
  • chills
  • cough
10+ years:
  • abdominal bloating
  • aphasia - primary progressive
  • apraxia
  • asthenia
  • burping
  • confusional state
  • constipation aggravated
  • cough
  • cyclic vomiting syndrome
  • death
not specified:
  • nausea
  • vomiting
  • pyrexia
  • pain
  • dyspnoea
  • diarrhoea
  • fatigue
  • headache
  • dehydration
  • anxiety

Most common drug interactions by gender *:

female:
  • nausea
  • vomiting
  • dyspnoea
  • diarrhoea
  • pyrexia
  • fatigue
  • pain
  • dehydration
  • headache
  • abdominal pain
male:
  • nausea
  • pyrexia
  • dyspnoea
  • pain
  • vomiting
  • pneumonia
  • diarrhoea
  • fatigue
  • hypotension
  • headache

Most common drug interactions by age *:

0-1:
  • abdominal distension
  • hypotension
  • maternal drugs affecting foetus
  • respiratory failure
  • blister
  • hypertension
  • multi-organ failure
  • neutropenia
  • premature baby
  • pyrexia
2-9:
  • pyrexia
  • vomiting
  • cough
  • nausea
  • diarrhoea
  • febrile neutropenia
  • tachycardia
  • somnolence
  • hypotension
  • headache
10-19:
  • vomiting
  • nausea
  • headache
  • pyrexia
  • hypotension
  • abdominal pain
  • pain
  • febrile neutropenia
  • hypokalaemia
  • neutropenia
20-29:
  • pain
  • nausea
  • anxiety
  • headache
  • dyspnoea
  • injury
  • vomiting
  • diarrhoea
  • syncope
  • fatigue
30-39:
  • vomiting
  • nausea
  • pain
  • cardiac arrest
  • dyspnoea
  • erythema
  • rash
  • haemorrhoids
  • anaemia
  • abdominal pain
40-49:
  • nausea
  • pain
  • pyrexia
  • headache
  • vomiting
  • dyspnoea
  • abdominal pain
  • fatigue
  • anxiety
  • dehydration
50-59:
  • nausea
  • dyspnoea
  • pyrexia
  • vomiting
  • diarrhoea
  • fatigue
  • pain
  • chest pain
  • asthenia
  • back pain
60+:
  • nausea
  • diarrhoea
  • vomiting
  • dyspnoea
  • fatigue
  • pyrexia
  • pneumonia
  • dehydration
  • asthenia
  • hypotension

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Zofran and Zantac?


Recent conversations of related support groups:

Can you answer these questions?

More questions for: Zofran, Zantac

You may be interested in these reviews

More reviews for: Zofran, Zantac

On eHealthMe, Zofran (ondansetron hydrochloride) is often used to treat nausea. Zantac (ranitidine hydrochloride) is often used to treat indigestion. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.